(firstQuint)A Crossover Safety Study of Ferumoxytol Versus Placebo.

 This is a double-blind, placebo controlled, crossover design study of the safety of ferumoxytol compared to placebo.

 Patients are randomized to receive either one 510 mg dose of ferumoxytol or the equivalent volume of normal saline followed by the other test article given one week later.

.

 A Crossover Safety Study of Ferumoxytol Versus Placebo@highlight

This crossover safety study will evaluate the safety of a single dose of ferumoxytol compared to placebo in patients with chronic kidney disease.

